Concepts (161)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neoplastic Cells, Circulating | 6 | 2016 | 933 | 0.990 |
Why?
|
| Germ-Line Mutation | 6 | 2022 | 1786 | 0.810 |
Why?
|
| von Hippel-Lindau Disease | 1 | 2021 | 152 | 0.740 |
Why?
|
| Genes, APC | 1 | 2020 | 159 | 0.730 |
Why?
|
| Carcinoma, Ductal, Breast | 2 | 2024 | 1101 | 0.730 |
Why?
|
| Magnetic Resonance Spectroscopy | 4 | 2013 | 3760 | 0.700 |
Why?
|
| Carcinoma, Lobular | 1 | 2024 | 484 | 0.690 |
Why?
|
| Adenomatous Polyposis Coli | 1 | 2020 | 224 | 0.670 |
Why?
|
| Carcinoma, Neuroendocrine | 1 | 2020 | 325 | 0.570 |
Why?
|
| Miniaturization | 2 | 2013 | 164 | 0.460 |
Why?
|
| Magnetite Nanoparticles | 2 | 2013 | 322 | 0.410 |
Why?
|
| Ferric Compounds | 1 | 2013 | 374 | 0.410 |
Why?
|
| Nucleic Acid Hybridization | 2 | 2007 | 1374 | 0.320 |
Why?
|
| Genomics | 7 | 2024 | 5692 | 0.320 |
Why?
|
| Thyroid Neoplasms | 1 | 2020 | 2274 | 0.300 |
Why?
|
| Metaphase | 1 | 2007 | 151 | 0.300 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2022 | 17400 | 0.270 |
Why?
|
| Melanoma | 2 | 2022 | 5462 | 0.270 |
Why?
|
| Breast Neoplasms | 4 | 2024 | 20774 | 0.260 |
Why?
|
| Pedigree | 3 | 2021 | 4646 | 0.250 |
Why?
|
| Antigens, Neoplasm | 2 | 2016 | 1983 | 0.240 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2006 | 323 | 0.230 |
Why?
|
| Laboratories | 2 | 2016 | 461 | 0.210 |
Why?
|
| Skin Neoplasms | 1 | 2022 | 5662 | 0.210 |
Why?
|
| Sequence Analysis, DNA | 4 | 2017 | 4801 | 0.210 |
Why?
|
| Nanoparticles | 1 | 2013 | 1902 | 0.210 |
Why?
|
| Chromosome Aberrations | 1 | 2007 | 1811 | 0.190 |
Why?
|
| Microphthalmia-Associated Transcription Factor | 1 | 2022 | 251 | 0.180 |
Why?
|
| Genetic Testing | 3 | 2018 | 3439 | 0.180 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2020 | 188 | 0.180 |
Why?
|
| Proto-Oncogene Proteins c-ret | 1 | 2020 | 220 | 0.170 |
Why?
|
| Incidental Findings | 3 | 2018 | 688 | 0.160 |
Why?
|
| Gene Expression Profiling | 4 | 2018 | 9410 | 0.160 |
Why?
|
| Disclosure | 3 | 2018 | 736 | 0.160 |
Why?
|
| Oncogenes | 1 | 2024 | 1263 | 0.150 |
Why?
|
| Chromosome Mapping | 1 | 2006 | 4742 | 0.150 |
Why?
|
| Lung Neoplasms | 4 | 2017 | 13019 | 0.150 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2006 | 3920 | 0.150 |
Why?
|
| Germ Cells | 1 | 2020 | 628 | 0.140 |
Why?
|
| Point-of-Care Systems | 2 | 2016 | 1175 | 0.140 |
Why?
|
| Databases, Genetic | 3 | 2022 | 1780 | 0.140 |
Why?
|
| Aged, 80 and over | 6 | 2021 | 57683 | 0.130 |
Why?
|
| Genome, Human | 2 | 2016 | 4420 | 0.130 |
Why?
|
| Neoplasms | 3 | 2013 | 21596 | 0.130 |
Why?
|
| Thyroidectomy | 1 | 2020 | 877 | 0.130 |
Why?
|
| Lung | 1 | 2013 | 9826 | 0.130 |
Why?
|
| Quantum Dots | 2 | 2006 | 172 | 0.120 |
Why?
|
| Genetic Counseling | 1 | 2018 | 600 | 0.120 |
Why?
|
| High-Throughput Nucleotide Sequencing | 4 | 2022 | 3585 | 0.110 |
Why?
|
| Phenotype | 2 | 2021 | 16331 | 0.110 |
Why?
|
| Click Chemistry | 1 | 2013 | 95 | 0.110 |
Why?
|
| Melanocytes | 1 | 2016 | 515 | 0.110 |
Why?
|
| Gold | 2 | 2008 | 483 | 0.110 |
Why?
|
| Genetic Variation | 2 | 2018 | 6540 | 0.100 |
Why?
|
| Humans | 25 | 2024 | 742088 | 0.100 |
Why?
|
| Software | 2 | 2022 | 4434 | 0.090 |
Why?
|
| Middle Aged | 7 | 2022 | 213127 | 0.090 |
Why?
|
| Cell Line, Tumor | 4 | 2016 | 16665 | 0.090 |
Why?
|
| Adult | 8 | 2021 | 213712 | 0.090 |
Why?
|
| Adenocarcinoma | 2 | 2017 | 6347 | 0.080 |
Why?
|
| Female | 11 | 2024 | 379592 | 0.080 |
Why?
|
| Nanotubes | 1 | 2008 | 77 | 0.070 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2018 | 1631 | 0.070 |
Why?
|
| Microdissection | 1 | 2007 | 152 | 0.070 |
Why?
|
| Biosensing Techniques | 1 | 2012 | 668 | 0.070 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2012 | 828 | 0.070 |
Why?
|
| Tissue Array Analysis | 1 | 2007 | 553 | 0.070 |
Why?
|
| Keratins | 1 | 2006 | 515 | 0.060 |
Why?
|
| Chromosomes, Human | 1 | 2007 | 457 | 0.060 |
Why?
|
| Paraffin Embedding | 1 | 2006 | 299 | 0.060 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2006 | 401 | 0.060 |
Why?
|
| Colonic Neoplasms | 1 | 2016 | 2542 | 0.060 |
Why?
|
| Sensitivity and Specificity | 2 | 2012 | 14720 | 0.060 |
Why?
|
| Cytological Techniques | 1 | 2006 | 219 | 0.060 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2018 | 8425 | 0.060 |
Why?
|
| Microarray Analysis | 1 | 2006 | 766 | 0.060 |
Why?
|
| Male | 7 | 2021 | 349538 | 0.060 |
Why?
|
| Metal Nanoparticles | 1 | 2008 | 403 | 0.060 |
Why?
|
| Lasers | 1 | 2007 | 952 | 0.050 |
Why?
|
| Neoplasm Transplantation | 1 | 2006 | 2085 | 0.050 |
Why?
|
| Cadherins | 1 | 2006 | 906 | 0.050 |
Why?
|
| Mutation | 2 | 2017 | 29717 | 0.050 |
Why?
|
| Mitosis | 1 | 2007 | 1208 | 0.050 |
Why?
|
| Radiography | 1 | 2013 | 7010 | 0.050 |
Why?
|
| DNA, Neoplasm | 1 | 2007 | 1758 | 0.050 |
Why?
|
| Mice, SCID | 1 | 2006 | 2715 | 0.050 |
Why?
|
| Database Management Systems | 1 | 2022 | 270 | 0.050 |
Why?
|
| Biopsy | 1 | 2013 | 6756 | 0.050 |
Why?
|
| Nanostructures | 1 | 2006 | 550 | 0.050 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2007 | 2638 | 0.050 |
Why?
|
| Pancreatic Neoplasms | 1 | 2018 | 5249 | 0.050 |
Why?
|
| Biomedical Research | 1 | 2016 | 3306 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 4751 | 0.040 |
Why?
|
| Genetic Markers | 1 | 2006 | 2633 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 1 | 2007 | 3612 | 0.040 |
Why?
|
| Transplantation, Heterologous | 1 | 2006 | 2382 | 0.040 |
Why?
|
| Child, Preschool | 1 | 2020 | 40955 | 0.040 |
Why?
|
| Aged | 4 | 2018 | 162944 | 0.040 |
Why?
|
| Workflow | 1 | 2022 | 846 | 0.040 |
Why?
|
| Colorectal Neoplasms | 1 | 2017 | 6754 | 0.040 |
Why?
|
| BRCA1 Protein | 1 | 2022 | 1145 | 0.030 |
Why?
|
| Intention | 1 | 2018 | 338 | 0.030 |
Why?
|
| Neoplasm Metastasis | 2 | 2016 | 4839 | 0.030 |
Why?
|
| False Positive Reactions | 1 | 2016 | 981 | 0.030 |
Why?
|
| Cyclooctanes | 1 | 2013 | 32 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2016 | 23387 | 0.030 |
Why?
|
| Research Report | 1 | 2016 | 355 | 0.030 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2006 | 3381 | 0.030 |
Why?
|
| Sample Size | 1 | 2016 | 844 | 0.030 |
Why?
|
| Child | 1 | 2020 | 77478 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2017 | 53187 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2007 | 13029 | 0.030 |
Why?
|
| Patients | 1 | 2018 | 892 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2016 | 1284 | 0.030 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2016 | 1093 | 0.030 |
Why?
|
| Evidence-Based Practice | 1 | 2016 | 500 | 0.030 |
Why?
|
| Family | 1 | 2022 | 3144 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2018 | 1525 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2013 | 40450 | 0.020 |
Why?
|
| HeLa Cells | 2 | 2008 | 3127 | 0.020 |
Why?
|
| Computational Biology | 1 | 2022 | 3518 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2018 | 2011 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2018 | 1707 | 0.020 |
Why?
|
| Guidelines as Topic | 1 | 2016 | 1402 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2008 | 12071 | 0.020 |
Why?
|
| DNA Repair | 1 | 2018 | 2042 | 0.020 |
Why?
|
| Information Dissemination | 1 | 2016 | 1100 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2006 | 21719 | 0.020 |
Why?
|
| Genotype | 1 | 2022 | 12946 | 0.020 |
Why?
|
| Young Adult | 1 | 2013 | 56350 | 0.020 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2016 | 2028 | 0.020 |
Why?
|
| Cell Separation | 1 | 2012 | 1749 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 2016 | 2714 | 0.020 |
Why?
|
| Cell Membrane Permeability | 1 | 2008 | 590 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2008 | 713 | 0.020 |
Why?
|
| Metabolic Clearance Rate | 1 | 2006 | 379 | 0.020 |
Why?
|
| Health Care Costs | 1 | 2018 | 3203 | 0.020 |
Why?
|
| Health Personnel | 1 | 2018 | 3210 | 0.020 |
Why?
|
| Antibodies | 1 | 2013 | 2459 | 0.020 |
Why?
|
| Surface Properties | 1 | 2008 | 1182 | 0.020 |
Why?
|
| Molecular Conformation | 1 | 2006 | 563 | 0.020 |
Why?
|
| Transferrin | 1 | 2006 | 295 | 0.020 |
Why?
|
| Decision Making | 1 | 2018 | 3869 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2022 | 19862 | 0.010 |
Why?
|
| Time Factors | 1 | 2006 | 40054 | 0.010 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2018 | 3915 | 0.010 |
Why?
|
| Particle Size | 1 | 2006 | 1640 | 0.010 |
Why?
|
| Prevalence | 1 | 2018 | 15194 | 0.010 |
Why?
|
| Antigens, Surface | 1 | 2006 | 1663 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2006 | 1539 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 2013 | 3691 | 0.010 |
Why?
|
| Mice | 1 | 2006 | 81045 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2016 | 7276 | 0.010 |
Why?
|
| Bone Marrow Cells | 1 | 2006 | 2513 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 2006 | 1915 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2006 | 77098 | 0.010 |
Why?
|
| Animals | 1 | 2006 | 168561 | 0.010 |
Why?
|
| Diagnostic Imaging | 1 | 2006 | 3507 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2016 | 35342 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2006 | 9274 | 0.010 |
Why?
|
| United States | 1 | 2016 | 69693 | 0.000 |
Why?
|
Concepts
(161)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(69)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_